Understanding the Side Effects of Wegovy: What Percentage of People Experience Them?

Last reviewed: June 26, 2026

Last updated: June 26, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Approximately 70% of patients starting GLP-1 medications like Wegovy report some form of gastrointestinal side effect during their first month of treatment. While most symptoms resolve or improve within weeks, knowing what to expect—and which reactions are temporary versus persistent—empowers you to stay committed to your health goals. PlexusDx offers compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan, giving you access to this transformative therapy without the brand-name price tag.

Most Common Semaglutide Side Effects and Their Frequency

Nausea ranks as the most frequently reported side effect, affecting roughly 25–40% of patients in the first few weeks of treatment. This sensation typically peaks during dose escalation phases and often diminishes once your body adjusts to the medication. Appetite suppression, while technically the desired therapeutic effect, can feel overwhelming to newcomers and contributes to reduced food intake that some describe as uncomfortable rather than welcome.

Vomiting occurs in approximately 10–15% of users, usually alongside nausea rather than as an isolated symptom. Constipation and diarrhea each affect 15–20% of patients, though they rarely occur together; most people experience one or the other depending on their baseline digestive habits and hydration patterns. Fatigue and general weakness show up in about 10–12% of cases, often linked to rapid calorie reduction rather than the medication itself.

Headaches and dizziness affect 5–10% of patients and typically resolve within the first month as your body stabilizes on the new medication. Reflux and stomach pain occur in fewer than 10% of users but tend to persist longer if lifestyle modifications—like eating smaller portions and avoiding trigger foods—aren't implemented alongside treatment.

Why Semaglutide Causes These Side Effects

Semaglutide binds to GLP-1 receptors in your gut and brain, slowing the speed at which food moves from your stomach into your intestines. This delayed gastric emptying is the mechanism that produces sustained fullness signals—the reason the drug works so well for weight loss. However, this same process can trigger nausea, bloating, and changes in bowel habits as your digestive system adapts to processing food more slowly.

The medication also directly activates nausea centers in your brain stem while suppressing appetite signals from your hypothalamus. For most patients, this dual effect becomes less noticeable after 3–4 weeks as the brain and gut develop tolerance. Starting with lower doses and titrating upward gradually—a practice called dose-escalation—allows your body to acclimate without overwhelming side effects.

Dehydration magnifies many semaglutide side effects because reduced food and fluid intake can happen simultaneously when appetite suppression is strong. Drinking enough water and consuming electrolyte-rich foods helps minimize headaches, dizziness, and constipation while you're on treatment.

Managing Side Effects: Timeline and Practical Strategies

Most gastrointestinal side effects peak during the first two weeks and decline significantly by week four. Nausea, the most bothersome symptom for many, typically reduces by 50% or more once your body acclimates. Staying at each dose level for at least one week before increasing—rather than jumping too quickly—allows your tolerance to build naturally and reduces the severity of adjustment reactions.

Eating smaller, more frequent meals with lean protein and low-fat options reduces gastric distress and maintains nutrient intake despite appetite suppression. Ginger tea, peppermint, and anti-nausea foods like crackers and broth can ease mild nausea without medication. Gentle walking and staying hydrated support digestion and help prevent constipation, while avoiding fatty and heavily seasoned foods prevents reflux and stomach discomfort.

If side effects become severe or persist beyond four weeks, PlexusDx providers can adjust your dose, extend your current dose level longer, or discuss alternative formulations like oral semaglutide if injection-based therapy causes ongoing issues. Some patients benefit from taking medication at different times of day or with specific meals, modifications that your PlexusDx care team can recommend based on your unique response.

Personalized Treatment: How Genetic Insights Improve Tolerability

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

By identifying genetic predispositions to nausea, constipation, or poor medication response, the Precision Peptide test helps PlexusDx providers personalize your dose escalation schedule and formulation choice. Patients with genetic markers suggesting slower tolerance may benefit from extended time at lower doses, while those with genetic patterns indicating strong receptor sensitivity might reach their optimal dose more quickly. This data-driven approach minimizes trial-and-error and keeps you on a treatment path matched to your biology.

PlexusDx compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan provide the same active ingredient as brand Wegovy but with the flexibility to adjust strength and formulation as your genetic profile and clinical response unfold. Combined with genetic insights, personalized dosing protocols, and clinical guidance, this approach delivers superior tolerability compared to standard one-size-fits-all treatment.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test ($298) to personalize your protocol from day one.

Frequently Asked Questions

How long do Wegovy side effects typically last?

Most patients experience peak side effects during the first two weeks and see substantial improvement by week four. Nausea, the most common reaction, typically reduces by 50% or more once your body adjusts. If side effects persist beyond four weeks, discuss dose adjustments or alternative formulations with your PlexusDx provider.

Is nausea from semaglutide dangerous, or will it go away?

Nausea from semaglutide is not dangerous, though it's uncomfortable. It stems from delayed stomach emptying and brain-based appetite suppression, both reversible as your body adapts. Eating smaller meals, staying hydrated, and taking medication with food can ease symptoms while you acclimate.

Can I use PlexusDx compounded semaglutide if I'm worried about side effects?

Yes. PlexusDx semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan with the same active ingredient as brand Wegovy but greater flexibility in dosing and formulation adjustments. Your PlexusDx provider can slow your dose escalation, switch to oral semaglutide, or tailor your protocol based on your side effect experience.

What percentage of people stop Wegovy due to side effects?

Clinical trials show approximately 8–12% of patients discontinue GLP-1 therapy specifically because of intolerable side effects, while the majority either adjust within weeks or find symptom management strategies effective. Proper dose escalation, meal planning, and hydration help most patients stay on treatment.

How can the PlexusDx Precision Peptide Genetic Test help reduce my side effects?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Wegovy Side Effects
• Mounjaro Side Effects Plexusdx
• Glp 1 Side Effects Plexusdx
• Tirzepatide Vs Semaglutide Side Effects

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.